Skip to main content
SpringerLink
Log in

Intracranial Atherosclerotic Disease

  • Chapter
  • First Online:
Catheter-Based Cardiovascular Interventions

  • 3179 Accesses

Abstract

Optimal medical therapy for symptomatic intracranial stenosis includes antiplatelet therapy and aggressive management of atherosclerotic medical conditions such as diabetes, hypertension, hyperlipidemia, and cigarette smoking. Systemic anticoagulation is not indicated. Two ongoing clinical trials are currently comparing angioplasty and stenting to medical management; the first report of one of these trials, SAMMPRIS, indicated that medical treatment may be superior to angioplasty and stenting. Angioplasty and stenting should be used with caution and be reserved for patients who remain actively symptomatic despite medical therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kunitz SC, Gross CR, Heyman A, Kase CS, Mohr JP, Price TR, Wolf PA (1984) The pilot Stroke Data Bank: definition, design, and data. Stroke 15(4):740–746

    Article  PubMed  CAS  Google Scholar 

  2. Chimowitz MI, Kokkinos J, Strong J, Brown MB, Levine SR, Silliman S, Pessin MS, Weichel E, Sila CA, Furlan AJ et al (1995) The warfarin-aspirin ­symptomatic intracranial disease study. Neurology 45(8):1488–1493

    Article  PubMed  CAS  Google Scholar 

  3. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG, Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators (2005) Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 352(13):1305–1316

    Article  PubMed  CAS  Google Scholar 

  4. McTaggart RA, Jayaraman MV, Haas RA, Feldmann E (2009) Intracranial atherosclerotic disease: epidemiology, imaging and treatment. Med Health R I 92(12):412–414, Review

    PubMed  Google Scholar 

  5. Suwanwela NC, Chutinetr A (2003) Risk factors for atherosclerosis of cervicocerebral arteries: intracranial versus extracranial. Neuroepidemiology 22(1):37–40

    Article  PubMed  Google Scholar 

  6. Wityk RJ, Lehman D, Klag M, Coresh J, Ahn H, Litt B (1996) Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 27(11):1974–1980

    Article  PubMed  CAS  Google Scholar 

  7. Huang HW, Guo MH, Lin RJ, Chen YL, Luo Q, Zhang Y, Wong KS (2007) Prevalence and risk factors of middle cerebral artery stenosis in asymptomatic residents in Rongqi County, Guangdong. Cerebrovasc Dis 24(1):111–115, Epub 2007 May 23

    Article  PubMed  Google Scholar 

  8. Feldmann E, Daneault N, Kwan E, Ho KJ, Pessin MS, Langenberg P, Caplan LR (1990) Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology 40(10):1541–1545

    Article  PubMed  CAS  Google Scholar 

  9. Kieffer SA, Takeya Y, Resch JA et al (1967) Racial differences in cerebrovascular disease: angiographic evaluation of Japanese and American populations. Am J Roentgenol 101:94–99

    CAS  Google Scholar 

  10. Bogousslavsky J, Barnett HJ, Fox AJ, Hachinski VC, Taylor W (1986) Atherosclerotic disease of the middle cerebral artery. Stroke 17(6):1112–1120

    Article  PubMed  CAS  Google Scholar 

  11. Mazighi M, Tanasescu R, Ducrocq X, Vicaut E, Bracard S, Houdart E, Woimant F (2006) Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology 66(8):1187–1191

    Article  PubMed  CAS  Google Scholar 

  12. López-Cancio E, Dorado L, Millán M, Reverté S, Suñol A, Massuet A, Mataró M, Galán A, Alzamora M, Pera G, Torán P, Dávalos A, Arenillas JF (2011) The population-based Barcelona-Asymptomatic Intracranial Atherosclerosis Study (ASIA): rationale and design. BMC Neurol 11:22

    Article  PubMed  Google Scholar 

  13. Qureshi AI, Feldmann E, Gomez CR, Johnston SC, Kasner SE, Quick DC, Rasmussen PA, Suri MF, Taylor RA, Zaidat OO (2009) Intracranial atherosclerotic disease: an update. Ann Neurol 66(6):730–738, Review

    Article  PubMed  CAS  Google Scholar 

  14. Kostner GM, Marth E, Pfeiffer KP, Wege H (1986) Apolipoproteins AI, AII and HDL phospholipids but not APO-B are risk indicators for occlusive cerebrovascular disease. Eur Neurol 25(5):346–354

    Article  PubMed  CAS  Google Scholar 

  15. Marzewski DJ, Furlan AJ, St Louis P, Little JR, Modic MT, Williams G (1982) Intracranial internal carotid artery stenosis: longterm prognosis. Stroke 13:821–824

    Article  PubMed  CAS  Google Scholar 

  16. Komotar RJ, Wilson DA, Mocco J, Jones JE, Connolly ES Jr, Lavine SD, Meyers PM (2006) Natural history of intracranial atherosclerosis: a critical review. Neurosurgery 58(4):595–601; discussion 595–601. Review

    Article  PubMed  Google Scholar 

  17. Qureshi AI, Ziai WC, Yahia AM, Mohammad Y, Sen S, Agarwal P, Zaidat OO, Suarez JI, Wityk RJ (2003) Stroke-free survival and its determinants in patients with symptomatic vertebrobasilar stenosis: a multicenter study. Neurosurgery 52:1033–1040

    Article  PubMed  Google Scholar 

  18. Voetsch B, DeWitt LD, Pessin MS, Caplan LR (2004) Basilar artery occlusive disease in the New England medical center posterior circulation registry. Arch Neurol 61:496–504

    Article  PubMed  Google Scholar 

  19. Akins PT, Pilgram TK, Cross DT 3rd, Moran CJ (1998) Natural history of stenosis from intracranial atherosclerosis by serial angiography. Stroke 29(2):433–438

    Article  PubMed  CAS  Google Scholar 

  20. Feldmann E, Wilterdink JL, Kosinski A, Lynn M, Chimowitz MI, Sarafin J, Smith HH, Nichols F, Rogg J, Cloft HJ, Wechsler L, Saver J, Levine SR, Tegeler C, Adams R, Sloan M, Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) Trial Investigators (2007) The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. Neurology 68(24):2099–2106

    Article  PubMed  CAS  Google Scholar 

  21. Nguyen-Huynh MN, Wintermark M, English J, Lam J, Vittinghoff E, Smith WS, Johnston SC (2008) How accurate is CT angiography in evaluating intracranial atherosclerotic disease? Stroke 39(4):1184–1188

    Article  PubMed  Google Scholar 

  22. Mori T, Fukuoka M, Kazita K, Mori K (1998) Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. AJNR Am J Neuroradiol 19(8):1525–1533

    PubMed  CAS  Google Scholar 

  23. Mori T, Fukuoka M, Kazita K (2000) Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. Interv Neuroradiol 6(Suppl 1):243–249

    PubMed  Google Scholar 

  24. The EC/IC Bypass Study Group (1985) Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. N Engl J Med 313(19):1191–1200

    Google Scholar 

  25. Amin-Hanjani S, Butler WE, Ogilvy CS, Carter BS, Barker FG 2nd (2005) Extracranial-intracranial bypass in the treatment of occlusive cerebrovascular disease and intracranial aneurysms in the United States between 1992 and 2001: a population-based study. J Neurosurg 103(5):794–804

    Article  PubMed  Google Scholar 

  26. Garrett MC, Komotar RJ, Starke RM, Merkow MB, Otten ML, Sciacca RR, Connolly ES (2009) The efficacy of direct extracranial-intracranial bypass in the treatment of symptomatic hemodynamic failure secondary to athero-occlusive disease: a systematic review. Clin Neurol Neurosurg 111(4):319–326

    Article  PubMed  Google Scholar 

  27. Garrett MC, Komotar RJ, Merkow MB, Starke RM, Otten ML, Connolly ES (2008) The extracranial-intracranial bypass trial: implications for future investigations. Neurosurg Focus 24(2):E4, Review

    Article  PubMed  Google Scholar 

  28. Takis C, Kwan ES, Pessin MS, Jacobs DH, Caplan LR (1997) Intracranial angioplasty: experience and complications. AJNR Am J Neuroradiol 18(9):1661–1668

    PubMed  CAS  Google Scholar 

  29. Marks MP, Marcellus ML, Do HM, Schraedley-Desmond PK, Steinberg GK, Tong DC, Albers GW (2005) Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up. AJNR Am J Neuroradiol 26(3):525–530

    PubMed  Google Scholar 

  30. Kim JT, Lee SH, Choi SM, Park MS, Kim BC, Yoon W, Kim JK, Kim MK, Cho KH (2009) Long-term durability of percutaneous transluminal angioplasty in patients with symptomatic middle cerebral artery stenosis. J Clin Neurol 5(1):24–28

    Article  PubMed  Google Scholar 

  31. Meyers PM, Schumacher HC, Tanji K, Higashida RT, Caplan LR (2007) Use of stents to treat intracranial cerebrovascular disease. Annu Rev Med 58:107–122, Review

    Article  PubMed  CAS  Google Scholar 

  32. Meyers PM, Schumacher HC, Higashida RT, Barnwell SL, Creager MA, Gupta R, McDougall CG, Pandey DK, Sacks D, Wechsler LR, American Heart Association (2009) Indications for the performance of intracranial endovascular neurointerventional procedures: a scientific statement from the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on…. Circulation 119(16):2235–2249

    Article  PubMed  Google Scholar 

  33. Kessler IM, Mounayer C, Piotin M, Spelle L, Vanzin JR, Moret J (2005) The use of balloon-expandable stents in the management of intracranial arterial diseases: a 5-year single-center experience. AJNR Am J Neuroradiol 26(9):2342–2348

    PubMed  Google Scholar 

  34. Fiorella D, Chow MM, Anderson M, Woo H, Rasmussen PA, Masaryk TJ (2007) A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease. Neurosurgery 61(2):236–242; discussion 242–243

    Article  PubMed  Google Scholar 

  35. SSYLVIA Study Investigators (2004) Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 35(6):1388–1392

    Article  Google Scholar 

  36. Kurre W, Berkefeld J, Sitzer M, Neumann-Haefelin T, du Mesnil de Rochemont R (2008) Treatment of symptomatic high-grade intracranial stenoses with the balloon-expandable Pharos stent: initial experience. Neuroradiology 50(8):701–708

    Article  PubMed  CAS  Google Scholar 

  37. Henkes H, Miloslavski E, Lowens S, Reinartz J, Liebig T, Kühne D (2005) Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan). Neuroradiology 47(3):222–228

    Article  PubMed  CAS  Google Scholar 

  38. Guo XB, Ma N, Hu XB, Guan S, Fan YM (2011) Wingspan stent for symptomatic M1 stenosis of middle cerebral artery. Eur J Radiol 80(3):e356–e360, Epub 2010 Dec 15

    Article  PubMed  Google Scholar 

  39. Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, Janis LS, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Torbey MT et al (2011) Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 365(11):993–1003

    Article  PubMed  CAS  Google Scholar 

  40. Chimowitz MI, Lynn MJ, Turan TN, Fiorella D, Lane BF, Janis S, Derdeyn CP, SAMMPRIS Investigators (2011) Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis 20(4):357–368

    Article  PubMed  Google Scholar 

  41. Leung TW, Yu SC, Wong KS (2011) Have medical therapy and stenting been fairly compared? A repercussion upon termination of recruitment in the SAMMPRIS trial. Int J Stroke 6(4):312–314

    Article  PubMed  Google Scholar 

  42. Holmes DR Jr (2006) Antiplatelet therapy after percutaneous coronary intervention. Cerebrovasc Dis 21(Suppl 1):25–34

    Article  PubMed  Google Scholar 

  43. Levy EI, Howington JU, Engh JA, Hanel RA, Levy N, Kim SH, Gibbons KJ, Guterman LR, Hopkins LN (2005) Submaximal angioplasty and staged stenting for severe posterior circulation intracranial stenosis: a technique in evolution. Neurocrit Care 2(2):189–197, Review

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurological Surgery, The Ohio State University Medical Center, Room N-1022 410 W. 10th Ave., Columbus, OH, 43210, USA

    Daniel S. Ikeda M.D., Evan S. Marlin M.D., Promod Pillai M.D. & Eric Sauvageau M.D.

Authors
  1. Daniel S. Ikeda M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Evan S. Marlin M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Promod Pillai M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eric Sauvageau M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eric Sauvageau M.D. .

Editor information

Editors and Affiliations

  1. , Dept. of Internal Medicine, Gesundheitszentrum Bitterfeld-Wolfen, Friedrich-Ludwig-Jahn-Straße 2, Bitterfeld-Wolfen, 06749, Germany

    Peter Lanzer

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Ikeda, D.S., Marlin, E.S., Pillai, P., Sauvageau, E. (2013). Intracranial Atherosclerotic Disease. In: Lanzer, P. (eds) Catheter-Based Cardiovascular Interventions. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27676-7_49

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-27676-7_49

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-27675-0

  • Online ISBN: 978-3-642-27676-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation